Literature DB >> 15483398

Distinct dynamics of Aurora B and Survivin during mitosis.

Marlène Delacour-Larose1, Annie Molla, Dimitrios A Skoufias, Robert L Margolis, Stefan Dimitrov.   

Abstract

We have studied the dynamics of Aurora B and Survivin during mitosis in living cells, using C-terminal GFP chimeras of the two proteins. These chimeras showed identical localization and behave as bona fide wild type proteins. The mobility of Aurora B-GFP and Survivin-GFP was analyzed by FRAP. The data show that Survivin-GFP, in contrast to Aurora B-GFP, is highly mobile at prometaphase and metaphase. At telophase and cell cleavage, both chimeras are found to be fully immobile. The ablation of Aurora B by siRNA results in a dramatic decrease of the Survivin-GFP mobility. These results demonstrate that Survivin, but not Aurora B, is weakly associated with the centromeric chromatin at prometaphase and metaphase. The weak association of Survivin with centromeric chromatin is dependent on the presence of Aurora B and is not affected by treatment with either nocodazole or taxol. The rapid and conditional interchange between passenger proteins that we show by live imaging indicates that the high affinity interactions demonstrated with in vitro analysis of passenger protein binding are, in fact, static "snapshots" of highly dynamic and regulated in vivo interactions in mitotic cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483398     DOI: 10.4161/cc.3.11.1203

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  20 in total

1.  Poriferan survivin exhibits a conserved regulatory role in the interconnected pathways of cell cycle and apoptosis.

Authors:  B Luthringer; S Isbert; W E G Müller; C Zilberberg; N L Thakur; G Wörheide; R H Stauber; M Kelve; M Wiens
Journal:  Cell Death Differ       Date:  2010-07-23       Impact factor: 15.828

2.  Role of survivin phosphorylation by aurora B in mitosis.

Authors:  Marlène Delacour-Larose; My-Nhung Hoang Thi; Stefan Dimitrov; Annie Molla
Journal:  Cell Cycle       Date:  2007-05-21       Impact factor: 4.534

Review 3.  Survivin study: an update of "what is the next wave"?

Authors:  Fengzhi Li; Xiang Ling
Journal:  J Cell Physiol       Date:  2006-09       Impact factor: 6.384

4.  Aurora B kinase, an immobile passenger!

Authors:  Marlène Delacour-Larose; Hong-Lien Vu; Annie Molla
Journal:  Cell Cycle       Date:  2009-11-27       Impact factor: 4.534

Review 5.  Welcome to a new kind of tension: translating kinetochore mechanics into a wait-anaphase signal.

Authors:  Thomas J Maresca; E D Salmon
Journal:  J Cell Sci       Date:  2010-03-15       Impact factor: 5.285

6.  Cytokinesis defines a spatial landmark for hepatocyte polarization and apical lumen formation.

Authors:  Ting Wang; Kilangsungla Yanger; Ben Z Stanger; Doris Cassio; Erfei Bi
Journal:  J Cell Sci       Date:  2014-04-04       Impact factor: 5.285

7.  Shugoshin 2 regulates localization of the chromosomal passenger proteins in fission yeast mitosis.

Authors:  Vincent Vanoosthuyse; Sergey Prykhozhij; Kevin G Hardwick
Journal:  Mol Biol Cell       Date:  2007-02-14       Impact factor: 4.138

Review 8.  Correcting aberrant kinetochore microtubule attachments: an Aurora B-centric view.

Authors:  Alexander E Kelly; Hironori Funabiki
Journal:  Curr Opin Cell Biol       Date:  2009-02       Impact factor: 8.382

9.  Perturbation of Incenp function impedes anaphase chromatid movements and chromosomal passenger protein flux at centromeres.

Authors:  Leena J Ahonen; Anu M Kukkonen; Jeroen Pouwels; Margaret A Bolton; Christopher D Jingle; P Todd Stukenberg; Marko J Kallio
Journal:  Chromosoma       Date:  2008-09-11       Impact factor: 4.316

10.  Benzo[e]pyridoindoles, novel inhibitors of the aurora kinases.

Authors:  Thi My-Nhung Hoang; Bertrand Favier; Annie Valette; Caroline Barette; Chi Hung Nguyen; Laurence Lafanechère; David S Grierson; Stéfan Dimitrov; Annie Molla
Journal:  Cell Cycle       Date:  2009-03-18       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.